Construction has begun on three new pharmaceutical production blocks at Ovison Pharma in Afghanistan's western Herat province, backed by a $30 million investment, while the factory has also opened a new serum and injectable production line.
According to sources, the new line can produce up to 100,000 packages of serum a day. The new blocks will be built on a 3,000-square-metre site, each rising five floors and fitted with advanced machinery designed to meet international standards.
The expansion is expected to significantly raise the plant's output and is seen as an important step toward strengthening Afghanistan's pharmaceutical industry, increasing domestic production and reducing reliance on imported medicines. Herat has emerged as a hub for new industrial investment, with the country's first modern aluminium wheel plant also starting production there this week.